TS
MJN

Thomas Steyer’s Mead Johnson Nutrition Company MJN Stock Holding History

Thomas Steyer’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-3,577,500
Closed -$319M – 96
2017
Q1 		$319M Buy
3,577,500
+1,689,047
+89% +$139M 3.5% 8
2016
Q4 		$134M Buy
+1,888,453
New +$141M 1.54% 24

Other funds holding MJN

PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
FNBOO
First National Bank of Omaha Omaha, Nebraska $3.55B AUM 27.24% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.54B AUM 37.12% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Thomas Steyer's MJN Position: Q2 2017 in Review

Thomas Steyer sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 3,577,500 shares — an estimated $319M sold.

Thomas Steyer first reported a position in MJN in Q4 2016 and held it in 2 quarters. The position peaked at $319M in Q1 2017. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Thomas Steyer reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Thomas Steyer sold 3,577,500 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $319M.
  • Thomas Steyer first reported a position in Mead Johnson Nutrition Company in Q4 2016 and held it in 2 quarters.
  • Thomas Steyer's Mead Johnson Nutrition Company position peaked at $319M in Q1 2017.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Farallon Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.